KOSDAQCosmetics439090

Manyo Factory

₩13,320▼ 2.35%2026-11-18 close
Market Cap
₩218.4B
Turnover
₩700M
Volume
50K
Shares out.
16.4M
PER
20.7×
PBR
2.0×
EPS
₩672
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit Peaked in Q1 2026; Watching the Slowdown and Overseas Mix

Manyo Factory's operating profit fell from KRW 24.5 billion in 2022 to KRW 10.5 billion in 2025, and after peaking in Q1 2026 it declined for two straight quarters to KRW 320 million in Q3 2026.

  1. 1

    Annual operating profit fell from KRW 24.5 billion in 2022 to KRW 10.5 billion in 2025, and operating margin dropped from 24.1% to 9.3%.

  2. 2

    Operating profit reached KRW 6.05 billion in Q1 2026 (sales of KRW 26.9 billion), the quarterly peak, then fell to KRW 2.52 billion in Q2 and KRW 320 million in Q3.

  3. 3

    Overseas sales and exports were 60.5% of the January–September 2025 cumulative total, and North American cumulative sales rose 47% on the year.

  4. 4

    Net income attributable to controlling shareholders totaled KRW 10.7 billion over the last four quarters, and Q3 2026 came in at KRW 61.31 million, down 97.7% on the year.

  5. 5

    The next checkpoints are the 2026 annual report and preliminary full-year 2026 results in early 2027, where the recovery of fourth-quarter profit is the key item.

02

Business structure

Manyo Factory manufactures and sells cosmetics, and its own products account for most of its revenue.

In the January–September 2025 cumulative total of KRW 87.3 billion, cleansing products made up 57%, ampoules and serums 21%, skincare 15%, and distribution of other companies' products 4.1% (KRW 3.5 billion cumulative).

By channel on the same cumulative basis, offline exports were KRW 31.2 billion (36%), online exports KRW 21.6 billion (25%), offline domestic KRW 20.3 billion (23%), and online domestic KRW 14.1 billion (16%). By customer type, B2B was KRW 51.8 billion (59%) and B2C KRW 35.5 billion (41%).

By region, Korea was KRW 34.5 billion (39%), Asia KRW 30.2 billion (35%), North America KRW 12.7 billion (15%), and other regions KRW 9.9 billion (11%), while overseas sales and exports totaled KRW 52.8 billion, or 60.5% of the total.

In 2023, the product mix was similar, with cleansing at 51%, ampoules and serums at 23%, and skincare at 21%, and Japan accounted for 57% of overseas sales, China 20%, and the United States 10%. A 2024 securities analysis noted that domestic sales depend heavily on Olive Young.

A June 2024 securities report said Japan remains the main overseas market while the United States is being considered as the next expansion market. North American cumulative sales rose 47% in the first nine months of 2025, but third-quarter sales alone fell 74% from the prior quarter.

Because the product lineup is concentrated in cleansing, demand shifts in that single category pass through to total sales quickly.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩28.7B₩4B14.0%
2025Q4₩25.8B₩2B7.9%
2026Q1₩26.9B₩6.1B22.5%
2026Q2₩25.8B₩2.5B9.8%
2026Q3₩24.6B₩300M1.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩101.8B₩24.5B₩17.3B24.1%33.2%20.4%
2023₩105B₩15.9B₩11.6B15.1%12.0%8.7%
2024₩127.9B₩18.6B₩16.4B14.5%14.4%13.8%
2025₩113B₩10.5B₩9.1B9.3%7.4%8.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

Annual sales and profit moved in different directions. Sales rose from KRW 101.8 billion in 2022 to KRW 105 billion in 2023 (up 3.1% on the year) and KRW 127.9 billion in 2024 (up 21.8%), then fell to KRW 113 billion in 2025 (down 11.7%), with 2024 the largest year in the 2022–2025 period.

Operating profit moved from KRW 24.5 billion in 2022 to KRW 15.9 billion in 2023 (down 35.2%), KRW 18.6 billion in 2024 (up 17.0%) and KRW 10.5 billion in 2025 (down 43.7%), making 2025 the smallest year in the period. In 2024 sales rose 21.8% but operating profit rose only 17.0%.

Securities analysts pointed to higher advertising and other selling expenses as a drag on margins from 2023, and consolidated advertising expenses were KRW 16.7 billion in 2023, KRW 23.6 billion in 2024 and KRW 21.6 billion in 2025 according to FnGuide financial data.

Advertising expenses in 2024 exceeded that year's operating profit of KRW 18.6 billion. Operating margin fell from 24.1% in 2022 to 15.1% in 2023, 14.5% in 2024 and 9.3% in 2025.

Net income attributable to controlling shareholders was KRW 17.3 billion in 2022, KRW 11.6 billion in 2023, KRW 16.4 billion in 2024 and KRW 9.13 billion in 2025, and 2024 showed a recovery with a 40.7% rise. Operating cash flow fell from KRW 18.1 billion in 2024 to KRW 11.1 billion in 2025.

On a quarterly basis, sales were KRW 28.7 billion and operating profit KRW 4.02 billion in Q3 2025, then fell in Q4 2025 to KRW 25.8 billion in sales (down 10.3% on the quarter) and KRW 2.03 billion in operating profit (down 49.4%).

Q1 2026 brought sales of KRW 26.9 billion (up 4.5% on the quarter) and operating profit of KRW 6.05 billion (up 197.8%), the quarterly peak. Q2 2026 sales were KRW 25.8 billion and operating profit KRW 2.52 billion.

Q3 2026 sales were KRW 24.6 billion (down 14.1% on the year), operating profit KRW 320 million (down 92.0% on the year), and net income attributable to controlling shareholders KRW 61.31 million (down 97.7% on the year).

Net income attributable to controlling shareholders totaled KRW 10.7 billion over the last four quarters. Advertising expenses in Q1 2026 were KRW 3.5 billion, down from KRW 6.1 billion a year earlier, but this figure alone does not explain the sharp fall in third-quarter profit alongside lower sales.

05

Industry analysis

The cosmetics sector includes both brand owners and contract manufacturers (ODM and OEM). Brand-led listed companies include Amorepacific, LG H&H and APR, while manufacturing-focused names include Cosmax and Kolmar Korea.

Manyo Factory sells its own brands directly and had a B2C share of 41% in the January–September 2025 cumulative total. Domestic sales depend heavily on Olive Young, so store policy and shelf placement flow directly into revenue.

Korean sales in the January–September 2025 cumulative total were KRW 34.5 billion, down 21% on the year, and Asian sales were KRW 30.2 billion, down 19%. North American sales rose 47% to KRW 12.7 billion, partly offsetting the weakness. China accounted for 20% of overseas sales in 2023.

Compared with overseas-distribution-led names such as Silicon 2 and d'Alba Global, Manyo Factory's distinguishing feature is its concentration in cleansing products, at 57% of sales.

06

Outlook

The recent trend is a decline in the second and third quarters of 2026 after the Q1 2026 peak. Q3 2026 operating profit fell to KRW 320 million, and net income attributable to controlling shareholders over the last four quarters totaled KRW 10.7 billion. Two variables matter going forward.

The first is whether sales recover toward the Q1 2026 level of KRW 26.9 billion. The second is whether advertising and other selling expenses are adjusted in line with lower sales; Q1 2026 advertising expenses were KRW 3.5 billion, down on the year.

Overseas, a securities analyst has described ongoing expansion in the United States, and North American cumulative sales rose 47% in the first nine months of 2025. Japan was 57% of overseas sales in 2023, so the Japan channel also needs to be tracked. Domestic sales hinge on Olive Young trends.

The next regular report is the 2026 annual report, and the first checkpoint is how its full-year sales and operating profit compare with the 2025 figures of KRW 113 billion and KRW 10.5 billion.

Preliminary full-year 2026 results may arrive around late February 2027, based on the timing of the 2025 annual release reported in late February 2026. Q1 2027 results are likely around May 2027, based on the May 14, 2026 release date for Q1 2026.

07

Valuation

PER
20.7×
PBR
2.0×
ROE
9.3%
EPS
₩672
BPS
₩6,781
Dividend per share
₩0

The share price sits above shareholders' equity of KRW 122.7 billion at the end of 2025, so the stock carries a premium over book value. On earnings, net income attributable to controlling shareholders over the last four quarters totaled KRW 10.7 billion, and the share price is high relative to that earnings base.

This reflects a share price that has held up while earnings declined. Compared with the KRW 17.3 billion of net income attributable to controlling shareholders in 2022, the earnings base is still short of its earlier level. Earnings rose 40.7% in 2024 but fell 44.2% in 2025.

The debt-to-equity ratio was 8.2% at the end of 2025, so financial leverage is low, and current financial assets stood at KRW 55.7 billion at the end of March 2026. The dividend yield is low, so cash returns through dividends are small.

The key variable for interpreting the multiples is whether earnings recover: a recovery would lower the earnings multiple at the same share price, and a further decline would raise it.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Rising overseas share

Overseas sales and exports were KRW 52.8 billion in the January–September 2025 cumulative total, or 60.5% of the total. North American cumulative sales rose 47% to KRW 12.7 billion. A 2024 securities analysis named the United States as the fastest-growing region. Whether overseas channels continue to offset domestic weakness is the next item to track.

Financial capacity and cash generation

Total liabilities were KRW 1 billion and total equity KRW 122.7 billion at the end of 2025, a debt-to-equity ratio of 8.2%. Current financial assets were KRW 55.7 billion at the end of March 2026.

Operating cash flow was KRW 18.1 billion in 2024 and KRW 11.1 billion in 2025, so cash generation continued relative to earnings. This capacity provides a base for marketing investment and overseas channel expansion.

Record of quarterly profit recovery

Operating profit rose 17.0% in 2024 and net income attributable to controlling shareholders rose 40.7%. Q1 2026 operating profit of KRW 6.05 billion and net income attributable to controlling shareholders of KRW 6.1 billion were the highest quarterly figures in the recent series.

Q1 2026 sales of KRW 26.9 billion were up 4.5% on the prior quarter. Whether that level of earnings power returns is the starting point for evaluating the trend.

09

Bear factors

Sharp quarterly profit slowdown

Q3 2026 operating profit was KRW 320 million, down 92.0% on the year. Net income attributable to controlling shareholders was KRW 61.31 million, down 97.7%. Profit has declined for two consecutive quarters after the Q1 peak.

Declines in Korea and Asia

Korean sales in the January–September 2025 cumulative total fell 21% to KRW 34.5 billion, and Asian sales fell 19% to KRW 30.2 billion. Online domestic cumulative sales fell 36% to KRW 14.1 billion. Q3 2026 sales of KRW 24.6 billion were down 14.1% on the year. Because sales declines came first, they serve as a bearish factor for profit.

Reliance on marketing spend

Advertising expenses of KRW 23.6 billion in 2024 exceeded that year's operating profit of KRW 18.6 billion. The margin is sensitive to how much is spent on advertising. Q1 2026 advertising expenses fell to KRW 3.5 billion, but if costs fall without a sales recovery, the margin benefit may be limited.

10

Risk factors

Channel concentration

A 2024 securities analysis said most domestic sales come through Olive Young. Changes in listing terms or store policy would flow directly into domestic revenue. Online domestic sales also fell 36% in the January–September 2025 cumulative total, leaving channel diversification as an open task.

Concentration by overseas country

Japan accounted for 57% of overseas sales in 2023, a high share. Japanese demand and yen exchange rate movements could feed through to revenue. China at 20% and the United States at 10% are also exposed to each country's regulations and customs conditions.

Product concentration and marketing efficiency

Cleansing products made up 57% of cumulative sales in the January–September 2025 period, making the company sensitive to demand shifts in one category. Advertising expenses were large at KRW 23.6 billion in 2024, so a decline in marketing efficiency could move margins sharply. The pace of product diversification remains a variable for profit recovery.

11

What to watch next

  1. Around late February 2027 (estimate)

    Preliminary full-year 2026 results. The timing is estimated from the late February 2026 release of 2025 annual results. Key points are whether fourth-quarter operating profit recovers from KRW 320 million in Q3 and whether the full-year operating margin rises above 9.3% recorded in 2025.

  2. Around March 2027 (estimate)

    Submission of the 2026 annual report. This is the next regular report and the first official document in which full-year sales and operating profit can be compared with the 2025 figures of KRW 113 billion and KRW 10.5 billion. Net income attributable to controlling shareholders relative to KRW 9.13 billion in 2025 also needs to be checked.

  3. Around May 2027 (estimate)

    Q1 2027 results. The timing is estimated from the May 14, 2026 release of Q1 2026 results. Points to check are the trend against the Q1 2026 peak of KRW 6.05 billion in operating profit and the level of advertising expenses against KRW 3.5 billion in Q1 2026.

12

Overall view

Manyo Factory's earnings have followed a pattern in which profit declined after sales peaked in 2024. Operating profit fell from KRW 24.5 billion in 2022 to KRW 10.5 billion in 2025, and operating margin dropped to 9.3%.

Operating profit peaked at KRW 6.05 billion in Q1 2026 but declined for two straight quarters, reaching KRW 320 million in Q3 2026. Bullish factors include overseas sales at 60.5% of the January–September 2025 total, rapid growth in North America, a low debt-to-equity ratio and steady cash generation.

Bearish factors include falling sales in Korea and Asia, a low margin relative to advertising spend, and concentration in cleansing products. On earnings, net income attributable to controlling shareholders over the last four quarters totaled KRW 10.7 billion, which has not yet returned to earlier levels.

The next checkpoints are the 2026 annual report, preliminary full-year 2026 results in early 2027, and Q1 2027 results, with sales recovery and the adjustment of selling expenses as the key items. This report is provided for information purposes.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. kr.investing.com
  2. edaily.co.kr
  3. comp.fnguide.com
  4. goinsider.kr
  5. m.thinkpool.com
  6. beautynury.com
  7. comp.fnguide.com
  8. news.nate.com
  9. ssl.pstatic.net
  10. beautynury.com
  11. beautynury.com
  12. m.jobkorea.co.kr
  13. beautynury.com
  14. sentv.co.kr
  15. hanaw.com
  16. theviewers.co.kr
  17. beautynury.com

Report written 2026-11-17 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis